June 9, 2025
Why GLP-1s May Be the Future of Medicine with Dr. Eric Rosenbaum
GLP-1 Hub: Support, Community, and Weight LossAbout this episode
Send us a text Trigger warning; Discussions of suicide and mental health concerns. In this conversation, Dr. Eric J. Rosenbaum discusses the transformative role of GLP-1 medications in weight loss and diabetes management. He emphasizes the importance of nutrition alongside these medications. We discuss the use of a product called Almased, a unique supplement that aids in weight management while preserving muscle mass. The discussion also covers the impact of GLP-1 on fatty liver disease, blood sugar regulation, and mental health, as well as the future of obesity treatments and the need for a comprehensive nutritional approach. About Dr. Rosenbaum Eric Rosenbaum, MD is a board-certified physician specializing in precision sports medicine, anti-aging medicine, and functional wellness. A graduate of Yale University, Dr. Rosenbaum completed his medical residency at Harvard Medical School/Spaulding Rehabilitation Hospital and pursued additional training at Cornell’s MBA/MS Healthcare Leadership program. Linkedin Get $5 off your first subscribe and save order of Almased here (affiliate link): Vanilla Orignial Visit our GLP-1 Hub store: https://www.glp-1hub.com Get our FREE 7-day meal plans for GLP-1: 7-Day Meal Plan Plant-based 7-Day Meal Plan Want to connect more with GLP-1 Hub? Instagram: https://www.instagram.com/glp1hub Tiktok: https://www.tiktok.com/@glp1hub YouTube: https://www.youtube.com/@glp-1hub Weekly newsletter with weight loss tips and podcast updates: https://glp1hub.myflodesk.com/rn9j3lxjpp *Some of the links shared are affiliate links. When you make a purchase, I will receive a small commission at no cost to you. Thank you for supporting the show. * The content of this show is for informational purposes only and does not constitute medical advice. The goal of this show is to provide various points of view about GLP-1 Medications. The personal and professional opinion of the guests and their content does not necessarily reflect the opinion of Ana Reisdorf or GLP-1 Hub.